Novonesis A S (NVZMF) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novonesis A/s Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.159 Ladies and gentlemen, welcome to the NOVESIS interim report for the first 00:00:05.159 -- 00:00:10.547 nine months of 2025 conference call. I'm Lorenzo, the chorus call operator. 00:00:10.547 -- 00:00:15.451 I would like to remind you that all participants will be in listen-only mode. 00:00:16.015 -- 00:00:18.839 The presentation will be followed by a Q&A session. 00:00:18.839 -- 00:00:23.626 You can register for questions at any time by pressing star and 1 on your telephone. 00:00:23.626 -- 00:00:27.031 For operator assistance, please press star and 0. 00:00:27.031 -- 00:00:31.089 The conference must not be recorded for publication or broadcast. 00:00:31.089 -- 00:00:35.609 At this time, it's my pleasure to hand over to Tobias Cornelius Bjorklund. 00:00:35.609 -- 00:00:38.168 Please go ahead. 00:00:38.168 -- 00:00:42.396 Thank you, operator, and welcome everyone to the NovoNesis conference call for the first 00:00:42.396 -- 00:00:45.601 nine months of 2025. As mentioned, my name is Tobias Björklund. 00:00:45.601 -- 00:00:48.687 I'm heading up investor relations here at NovoNesis. 00:00:48.687 -- 00:00:53.376 In this call, our CEO, Esther Barchett, and our CFO, Reiner Lehmann, will review our 00:00:53.376 -- 00:00:58.064 performance for the first nine months of the year, as well as the outlook for 2025. 00:00:58.064 -- 00:01:03.313 Attending today's call, we also have Tina Fehrner, EVP of Planetary Health Biosolutions, 00:01:03.313 -- 00:01:07.901 Henrik-Jörg Nilsson, EVP of Human Health Biosolutions, Andrew Taylor, EVP of Food and 00:01:07.901 -- 00:01:12.629 Health Biosolutions, and Klaus-Krone Fuglsang, Chief Scientific Officer. 00:01:12.629 -- 00:01:15.935 The conference call will take about 45 minutes, including Q&A. 00:01:15....